These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11150263)
1. Clinicopathologic findings in eyes with retained perfluoro-n-octane liquid. Elsing SH; Fekrat S; Green WR; Chang S; Wajer SD; Haller JA Ophthalmology; 2001 Jan; 108(1):45-8. PubMed ID: 11150263 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study. Scott IU; Flynn HW; Murray TG; Feuer WJ; Am J Ophthalmol; 2003 Sep; 136(3):454-63. PubMed ID: 12967798 [TBL] [Abstract][Full Text] [Related]
3. Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane. Scott IU; Murray TG; Flynn HW; Feuer WJ; Schiffman JC; Ophthalmology; 2002 Oct; 109(10):1828-33. PubMed ID: 12359602 [TBL] [Abstract][Full Text] [Related]
4. Perfluoroperhydrophenanthrene versus perfluoro-n-octane in vitreoretinal surgery. Loewenstein A; Humayun MS; de Juan E; Campochiaro PA; Haller JA Ophthalmology; 2000 Jun; 107(6):1078-82. PubMed ID: 10857826 [TBL] [Abstract][Full Text] [Related]
5. Foreign body response within postoperative perfluoro-N-octane for retinal detachment repair: clinical features, grading system, and histopathology. Sigler EJ; Randolph JC; Charles S Retina; 2014 Feb; 34(2):237-46. PubMed ID: 23881228 [TBL] [Abstract][Full Text] [Related]
6. Retained Intraocular Perfluoro-n-octane After Valved Cannula Pars Plana Vitrectomy for Retinal Detachment. Oellers P; Schneider EW; Fekrat S; Mahmoud TH; Mruthyunjaya P; Hahn P Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):451-6. PubMed ID: 25970866 [TBL] [Abstract][Full Text] [Related]
7. 25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears. Randolph JC; Diaz RI; Sigler EJ; Calzada JI; Charles S Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):253-7. PubMed ID: 25959143 [TBL] [Abstract][Full Text] [Related]
9. Outcomes and complications associated with perfluoro-n-octane and perfluoroperhydrophenanthrene in complex retinal detachment repair. Scott IU; Murray TG; Flynn HW; Smiddy WE; Feuer WJ; Schiffman JC Ophthalmology; 2000 May; 107(5):860-5. PubMed ID: 10811075 [TBL] [Abstract][Full Text] [Related]
10. 25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane tamponade for inferior retinal detachment. Sigler EJ; Randolph JC; Calzada JI; Charles S Ophthalmic Surg Lasers Imaging Retina; 2013; 44(1):34-40. PubMed ID: 23418732 [TBL] [Abstract][Full Text] [Related]
11. Further evidence for proinflammatory nature of perfluorohexyloctane in the eye. Vote B; Wheen L; Cluroe A; Teoh H; McGeorge A Clin Exp Ophthalmol; 2003 Oct; 31(5):408-14. PubMed ID: 14516428 [TBL] [Abstract][Full Text] [Related]
12. Recurrent retinal detachment more than 1 year after reattachment. Foster RE; Meyers SM Ophthalmology; 2002 Oct; 109(10):1821-7. PubMed ID: 12359601 [TBL] [Abstract][Full Text] [Related]